Akari Therapeutics plc (AKTX)
Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment
Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment
The Gross Law Firm Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX
The Gross Law Firm Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in Frances Real-World Evaluation of Early Detection of Sepsis
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM
The Gross Law Firm Notifies Shareholders of Baxter International, Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline
Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Society of Hematology (ASH) Annual Meeting 2025 on Tuesday, December 9th at 8:00 AM ET
Propanc Biopharma Investigates “Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs
Citius Oncology - Citius Oncology ExpandsLYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim